Capital Performance Advisors’s Amphenol APH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
1,914
-3,485
-65% -$502K 0.02% 216
2026
Q1
$682K Sell
5,399
-6
-0.1% -$845 0.05% 172
2025
Q4
$730K Buy
5,405
+333
+7% +$44.5K 0.05% 159
2025
Q3
$628K Buy
5,072
+1,842
+57% +$202K 0.1% 104
2025
Q2
$319K Sell
3,230
-1,390
-30% -$114K 0.06% 150
2025
Q1
$303K Buy
+4,620
New +$315K 0.07% 156
2024
Q4
Sell
-349
Closed -$22.7K 323
2024
Q3
$22.7K Buy
+349
New +$22.6K 0.01% 570

Other funds holding APH

Capital Performance Advisors's APH Position: Q2 2026 in Review

Capital Performance Advisors reduced its Amphenol (APH) stake by 65% in Q2 2026, selling an estimated $502K and leaving 1,914 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #216.

Capital Performance Advisors first reported a position in APH in Q3 2024 and has held it in 7 quarters since. The position peaked at $730K in Q4 2025. 2,321 funds tracked by Wall St. Rank hold APH as of Q2 2026.

  • Capital Performance Advisors held 1,914 shares of Amphenol worth $337K as of Q2 2026.
  • Capital Performance Advisors sold 3,485 Amphenol shares in Q2 2026, an estimated $502K.
  • Amphenol made up 0.02% of Capital Performance Advisors's portfolio in Q2 2026, its #216 holding.
  • Capital Performance Advisors first reported a position in Amphenol in Q3 2024 and has held it in 7 quarters since.
  • Capital Performance Advisors's Amphenol position peaked at $730K in Q4 2025.
  • 2,321 funds tracked by Wall St. Rank held Amphenol as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.